Introduction
Most patients in septic shock can be managed successfully with the appropriate antibiotics in large doses, intravenous fluids, the use of oxygen, and timely surgery where applicable-in particular, drainage of closed foci of infection (Nickerson, 1962; Walters and McGowan, 1963; Frank, 1964; Lillehei et al., 1964; Baue, 1968; Blair et al., 1969) . Vasodilator drugs, however, are recommended in patients who do not respond to adequate transfusion (Lancet, 1965) . Examples of such drugs are hydrocortisone in massive doses, phenoxybenzamine, isoprenaline, chlorpromnazine, and phentolamine.
The indications, dose, response, and side-effects of adjuvant intravenous isoprenaline in the treatment of septic shock are described. Prognosis is considered in relation to the severity of the shock syndrome. Isoprenaline was found useful in patients in whom hypotension was associated with small pulse volume and warm or cold extremities. On the other hand, with the limited resources available, it did not appreciably improve the outlook for patients who had both pulmonary oedema and acute renal failure. 
Patients and Methods
A prospective study was carried out on 12 patients in the Korle Bu Teaching Hospital, Accra, Ghana, who were in septic shock and in whom conventional antishock therapy had failed. Of these, 10 were women and 2 men, their ages ranging from 16 to 60 years.
All patients had severe bacterial infection associated with the following features: low blood pressure, which in five cases was unrecordable, while in the remainder the systolic was 90 mm. Hg or lower; radial pulse rates of between 110 and 172 beats/min., which was of small volume in nine cases, imperceptible in one, but collapsing in character in two; cutaneous vasoconstriction associated with sweating (cold, clammy extremities), which was present in half the cases while extremities were warm and dry in the rest. All patients were pyrexial, with rectal temperatures ranging between 100 and 108°F. and 42.20C.) (though patients in septic shock may have subnormal temperatures). Oliguria (urine output below 20 ml./hr.) was present in half the cases, including three with acute renal failure.
Thus according to the clinical classification proposed by McGowan and Walters (1966) there were six patients with "cold hypotension," one with "warm hypotension," four in whom hypotension was associated with warm extremities but small pulse volume, and one with hypotension, cold extremities, but good pulse volume.
Central venous pressure, urinary output, and electrocardiogram were monitored as well as pulse, blood pressure, temperature, and respiration. (Cardiac output, pH, Pco2, and Po2 could not be measured because of lack of facilities.)
Blood pressure was measured by means of a sphygmomanometer (Kardos, 1966) . Furthermore, the comment that "blood pressure is, in our experience, still best measured by the mercury sphygmomanometer at the bedside and only in special cases via an indwelling arterial cannula" (Campbell et al., 1967) (Innes and Nickerson, 1960) , which in turn improves tissue perfusion.
Indications.-Isoprenaline was not used routinely in this series. For example both Cases 5 and 12 were treated successfully with antibiotics and intravenous fluids. But isoprenaline was used in cases of "occult myocardial failure" (Siegel and Fabian, 1967) The 10 patients who received isoprenaline in this series may be grouped as follows (see Table) . Two had hypotension with small pulse volume and warm extremities without oliguria (Cases 1 and 2); three had hypotension with small pulse volume and cold extremities without oliguria (Cases 3, 4, and 6); and four had "cold hypotension" with oliguria (Cases 7, 8, 10, and 11). Case 9 was an exception; she had hypotension with warm extremities and "bounding" radial pulse, but she was also oliguric. This At laparotomy purulent peritonitis due to ruptured secondary abdominal pregnancy with placenta attached to broad ligament was found. A macerated fetus weighing 21 lb. (1-1 kg.) was removed and a left salpingo-oophorectomy performed. After peritoneal toilet the abdomen was closed in layers with drainage. The patient received 2 pints (1,140 ml.) of blood during the procedure and antibiotic therapy was begun. She collapsed suddenly 10 hours later with unrecordable blood pressure, imperceptible radial pulse, cold clammy extremities, and a clouded sensorium. At this stage she was moved to an intensive care unit. Serum electrolyte levels were: sodium 119, potassium 5.0, chloride 118 mEq/l.; blood urea was 32 mg./100 ml.; total bilirubin 6-0 mg./100 ml.; standard bicarbonate 28 mEq/l.; haemoglobin 12.9 g./100 ml.; white cell count 12,650/cu. mm.
The patient remained gravely ill over the next 12 hours, with a labile blood pressure (Fig. 2) Serum electrolyte levels were: sodium 140, potassium 3.7, and chloride 104 mEq/l.; blood urea was 256 mg./100 ml.; total serum bilirubin 1-8 mg./100 ml.; standard bicarbonate 22 mEq/l.; haemoglobin 9.0 g./100 ml.; packed cell volume 31%; white cell count 50,050/cu. mm. Two blood cultures were negative.
Isoprenaline infusion was begun because the patient's condition was deteriorating visibly; the blood pressure was falling despite increasing the rate of intravenous fluids. A further drop in systolic pressure was anticipated because the central venous pressure was low. The dose of isoprenaline used was between 0-4 and 0.6 ,ug./min. A drop in systolic pressure did occur after a transient rise, but it was matched by giving more intravenous fluids. Central venous pressure remained low throughout (Fig. 3) . Urine output, which had been nil for 11 hours before isoprenaline was given, increased briskly. At the height of the diuresis 196 ml./hour was recorded. The blood urea was 256 mg./100 ml. at the beginning of treatment and it remained high at 280 mg./ 100 ml. three days later, despite continuing diuresis. The patient survived the shock episode, but died a week later of bilateral lobar pneumonia.
Discussion
The rationale behind the use of isoprenaline in septic shock stems from three observations.
Firstly, heart failure due to a primary depressant effect of endotoxin on the myocardium occurs in some cases of septic shock (MacLean et al., 1965; McGowan and Walters, 1966; Anderson et al., 1967; Siegel and Fabian, 1967; Starzecki and Spink, 1968) . This view, however, is not universally accepted (Vaughn et al., 1968) . In practice, isoprenaline improves survival in experimental endotoxic shock (Halmagyi et al., 1963; Vick et al., 1965; Siegel and Fabian, 1967; Starzecki and Spink, 1968) , and there are favourable reports of isoprenaline as an adjuvant in the management of septic shock in man (MacLean et al., 1965; Kardos, 1966; Du Toit et al., 1966; Baue, 1968) . Vasodilator drugs are recommended for patients in shock who do not respond to adequate transfusion (Lancet, 1965) . When "warm hypotension" persists in spite of a raised central venous pressure additional isoprenaline is probably not required, since the peripheral circulation is probably adequate and nothing more than lowering central venous pressure and increasing systolic pressure may be achieved.
Secondly, renal failure may complicate septic shock by the dual mechanism of direct and reflex vasoconstriction in the renal vascular tree, and isoprenaline abolishes both (Siegel and Fabian, 1967 Walters, 1966; MacLean, 1966) . Five patients in this series (Cases 1-4 and 6) had hypotension with smallvolume radial pulse but good urine output, while Cases 3, 4, and 6 also had cold and clammy extremities. Once the infection had been controlled, additional isoprenaline expedited the recovery of all except one patient (Case 3), who was too ill to tolerate drainage of pelvic abscess.
Thirdly, in the lungs, Halmagyi et al. (1965) showed that isoprenaline rapidly abolished both vasoconstriction and closure of alveolar ducts in sheep.
Massive pulmonary oedema is a recognized serious complicaton of septic shock (Frank, 1964; Kardos, 1966; Riordan and Walters, 1968) . In the present series, of the five patients who died during the acute phase with pulmonary oedema, three also had acute renal failure. The association of pulmonary oedema and renal failure indicates a poor prognosis (Riordan and Walters, 1968) . With the limited resources available for this study, isoprenaline did not appreciably alter the outlook for these patients.
In this study the following effects of intravenous isoprenaline were observed. Sinus tachycardia occurred immediately in all cases, with rates between 120 and 160 beats per minute. In one patient (Case 10) ventricular ectopic beats appeared, whereas in all cases the radial pulse became more readily palpable, of better volume, and collapsing in character, the extremities became warmer, pulsations were felt in digital vessels, and cold perspiration ceased. Six patients complained of palpitation, while in one patient (Case 7) an extensive desquamation of skin was observed. The effect on blood pressure was variable; the expected effect of a rise in systolic and fall in diastolic pressure occurred only infrequently. In general, the systolic pressure rose provided the central venous pressure was adequate (3120 mm. H20) Central venous pressure, however, tended to fall during isoprenaline infusion.
Though urinary output improved in all cases except two, it is noteworthy that a copious diuresis of about 100 ml./hour had the same grave prognostic significance as oliguria, since both indicated impaired renal function (Spink, 1962) .
The above observations agree with the conclusion of Mac- Lean (1966) that "in the absence of cardiac output determinations a favourable response to isoprenaline consists of increased heart rate, increase in arterial blood pressure, fall in central venous pressure, and increased urine output."
In 6 out of the 10 cases the dose of 0.2-0.6 ,ug./min. was satisfactory and the drug was discontinued without subsequent difficulty. In the remaining four cases, however, difficulties in weaning patients off isoprenaline and the need for progressively larger doses were associated with persistently high central venous pressure, massive pulmonary oedema, and impaired kidney function.
